Onderneming Pain Therapeutics, Inc. Nasdaq
Aandelen
US69562K5065
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01-05-98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01-10-18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04-01-21 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 01-06-98 | |
Robert Cook
LAW | General Counsel | 60 | 01-10-22 |
Michael Marsman
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01-05-98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01-03-03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-07 |
Director/Board Member | 92 | 01-09-98 | |
Richard Barry
BRD | Director/Board Member | 65 | 11-06-21 |
Director/Board Member | 65 | 01-06-98 | |
Claude Nicaise
BRD | Director/Board Member | 71 | 07/12 |
Robert Anderson
BRD | Director/Board Member | 58 | 07/12 |
Pierre Gravier
BRD | Director/Board Member | 39 | 07/12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 976 166 | 44 808 216 ( 93,40 %) | 0 | 93,40 % |
Bedrijfsgegevens
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.com![Adres Pain Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/34858163.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,24% | 127 mld. | |
+23,91% | 117 mld. | |
+26,40% | 27,67 mld. | |
-19,65% | 20,33 mld. | |
-15,99% | 16,79 mld. | |
-18,19% | 15,63 mld. | |
+13,44% | 14,84 mld. | |
-47,70% | 14,65 mld. | |
+58,66% | 14,43 mld. |